DFSVX | NWHGX | DFSVX / NWHGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 32 years | 11 years | - |
Gain YTD | 10.165 | 0.737 | 1,379% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.4B | 104M | 15,769% |
Annual Yield % from dividends | 1.44 | 1.57 | 92% |
Returns for 1 year | 9.80 | 0.43 | 2,278% |
Returns for 3 years | 17.58 | 0.06 | 31,584% |
Returns for 5 years | 48.02 | 38.85 | 124% |
Returns for 10 years | 45.74 | 37.86 | 121% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLGB | 26.36 | 0.19 | +0.71% |
Franklin FTSE United Kingdom ETF | |||
FEP | 35.96 | 0.22 | +0.63% |
First Trust Europe AlphaDEX® ETF | |||
FDCF | 38.84 | 0.24 | +0.63% |
Fidelity Disruptive Communications ETF | |||
GUNR | 36.45 | 0.09 | +0.25% |
FlexShares Mstar Glbl Upstrm Nat Res ETF | |||
CNCR | 12.35 | 0.03 | +0.24% |
Range Cancer Therapeutics ETF |